about
Current and emerging azole antifungal agentsAzole fungicides affect mammalian steroidogenesis by inhibiting sterol 14 alpha-demethylase and aromatase.Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infantsFluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis.Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates.Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole.Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.1-Phenyl-2-(1H-1,2,4-triazol-1-yl)ethanol1-Phenyl-2-(1H-1,2,4-triazol-1-yl)ethanoneCandida and oral candidosis: a review.Fluconazole concentrations in saliva from AIDS patients with oropharyngeal candidosis refractory to treatment with fluconazoleMonoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi.Effect of fluconazole on viability of Candida albicans over extended periods of timeAntifungal therapy: from amphotericin B to present.Investigation of microemulsion system for transdermal delivery of itraconazoleMultisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolatesSelection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.Azoles and antidepressants: a mini-review of the tolerability of co-administration.The reformulation of amphotericin B for oral administration to treat systemic fungal infections and visceral leishmaniasis.Drug safety assessment of oral formulations of ketoconazole.Treatment considerations in pulmonary coccidioidomycosis.Synthetic antimicrobial β-peptide in dual-treatment with fluconazole or ketoconazole enhances the in vitro inhibition of planktonic and biofilm Candida albicans.Skin rash in a renal transplant recipient.Variation in Microbial Identification System accuracy for yeast identification depending on commercial source of Sabouraud dextrose agar.Therapeutic efficacy of human macrophage colony-stimulating factor, used alone and in combination with antifungal agents, in mice with systemic Candida albicans infection.Urinary tract candidiasis in neonates and infants.Limitations of the current microbial identification system for identification of clinical yeast isolatesEffect of prolonged fluconazole treatment on Candida albicans in diffusion chambers implanted into mice.Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patientsFungal infections in neutropenic patients. A 8-year prospective study.What's new in fungal infection in leukemic patients.Profiling of the effects of antifungal agents on yeast cells based on morphometric analysis.Antifungal therapy in the oral cavity.Fluconazole Resistance Candida albicans in Females With Recurrent Vaginitis and Pir1 Overexpression.Synthesis, anticandidal activity and cytotoxicity of some tetrazole derivatives.Femoral osteomyelitis due to Cladophialophora arxii in a patient with chronic granulomatous disease.Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis.
P2860
Q24550733-79680EFA-3D81-472B-8923-25ACEEC67074Q24813721-FE5ED541-8EB0-4527-B92F-0A465470EFF7Q30435365-C876E06D-2FF2-44A5-80DC-9E522F7B830BQ30744536-594FA995-98BE-4ADE-8704-0ECF73F86FB7Q33688448-74ED10F4-199C-46EF-ADF1-2AE8E1DE0E72Q33758350-41271E00-2983-458B-98DB-A14DDAFBC9BCQ33959121-EAB15297-54DA-4E84-8D52-79F2244C232FQ34052582-F50E6456-714D-4137-8FB2-D884176CA645Q34229934-5AC667AE-F99A-46AE-92B2-5B7A383079DEQ34230989-F1B4EEB8-8187-4450-97B1-1F3DA6C27D08Q34318789-BAE24BE9-83EA-4C70-A3F2-A3CCE54FB9D3Q35112281-EE1F7736-5A37-46BB-8EAF-EA50EBCB37CDQ35115708-560D7185-7435-4BF1-AC7F-8C75CF5C7250Q35126781-8B91DAEE-B748-410C-9C8D-7F05BCCEE656Q35129406-87403056-6FAF-41EC-99DA-D42EF1C80376Q35245371-CBA1C282-7A85-4D1C-AB60-28172F0877C6Q35554483-FD958008-A633-40E4-8405-17305E21B114Q37087471-0AED6765-1D81-41D6-B06D-4E563EAF0703Q37087657-1A11AEFE-34DE-4B2A-B26A-757A77ECD66BQ37389855-23664745-FB10-4ABF-A58E-21B37749D607Q37425218-554B0E24-DA41-4E61-A07B-D3271DDAC5EBQ38269550-3AD3363E-4A0E-4B6F-AFB0-7A3A9798D32CQ38820536-6AA25625-77A0-4C84-B764-8FE7ACD6BB43Q38827664-C6073316-F8FD-4C1C-9343-C09C93E72FACQ39079584-3B218217-3FFF-43E8-813D-D441483529EEQ39449968-B57040CB-C72E-446D-8D44-20ECEC8DB0DDQ39472534-889849BD-A2A5-4B0F-8B85-2DC987586611Q39472935-BF2F6571-78DB-4437-BE72-9E00D0BE8A7EQ39553582-1756D891-9099-42A4-8EEC-B87142C6AF2BQ39658166-832DB518-0024-4024-80E5-4A46C64120ECQ39866233-D1C53F2A-6B87-43A3-A8DF-FE0E77BCC12AQ39866778-28E2366F-9523-49BA-958B-A522F8ED4011Q40680262-4DE071AE-D16F-4A00-8EE9-8A6E10634E1DQ40722965-D3C068AD-DB05-42D9-A8F1-2D8B5FAF518CQ40844582-393EF7A7-51AD-4E9B-944A-E8D003120E00Q41754780-971C19C7-F5EC-42F7-8158-6CF341D13E05Q42133066-6F7F5947-81AE-49DB-B3CF-DAA2B6E02AB1Q42826676-20844DA1-49F0-495B-8A63-C1552DFB17A1Q43294590-97CFA0A0-C33A-4304-9CC3-BE99E835A189Q43696321-04257FEB-D40D-43E7-ACB3-0721D9E18D45
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Azole antifungal agents.
@ast
Azole antifungal agents.
@en
type
label
Azole antifungal agents.
@ast
Azole antifungal agents.
@en
prefLabel
Azole antifungal agents.
@ast
Azole antifungal agents.
@en
P1476
Azole antifungal agents.
@en
P2093
P304
P356
10.1093/CLINIDS/14.SUPPLEMENT_1.S161
P407
P478
14 Suppl 1
P577
1992-03-01T00:00:00Z